BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7923307)

  • 1. In vitro effects of trapidil on fatty acid and prostaglandin metabolism in platelets.
    Tohjima T; Arisaka T; Honda N
    Clin Ther; 1994; 16(3):405-15. PubMed ID: 7923307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets.
    O'Barr TP; Swanson EW; Fitzpatrick JE; Corby DG
    J Lab Clin Med; 1989 Nov; 114(5):575-8. PubMed ID: 2553835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
    Mazurov AV; Leĭtin VL; Repin VS
    Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dietary linoleic acid on the platelet aggregation, fatty acid composition of platelet phospholipids and synthesis of platelet prostaglandins in rats].
    Markov KhM; Atrokhov VV; Zadkova GF; Pinelis VG; Poleshchuk VS
    Vopr Med Khim; 1988; 34(4):37-41. PubMed ID: 3195130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thromboxane B2 formation of blood platelets by trapidil and other s-triazolo(1,5-a)pyrimidine derivatives.
    Block HU; Hoffmann-Heinroth I; Taube C; Niebisch M; Mest HJ
    Prostaglandins Leukot Med; 1987 Dec; 30(2-3):77-86. PubMed ID: 2827193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets].
    Yu W; Xu L
    Yao Xue Xue Bao; 1998; 33(1):62-3. PubMed ID: 11938938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates.
    Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Taube C; Förster V
    Thromb Res; 1983 Nov; 32(3):255-66. PubMed ID: 6419377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
    Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
    Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane production by platelets during tumor cell-induced platelet activation.
    Pacchiarini L; Zucchella M; Milanesi G; Tacconi F; Bonomi E; Canevari A; Grignani G
    Invasion Metastasis; 1991; 11(2):102-9. PubMed ID: 1917383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.